clindamycin has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, KA; Kemperman, M; Kline, SE; Perry, EH; Wudhikarn, K | 1 |
| Alonso, V; Jordá, E; Martín, JM; Molina, I; Monteagudo, C; Ramón, D | 1 |
1 review(s) available for clindamycin and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Transfusion-transmitted babesiosis in an immunocompromised patient: a case report and review.
Topics: Anti-Bacterial Agents; Antimalarials; Antineoplastic Agents; Babesia microti; Babesiosis; Clindamycin; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Opportunistic Infections; Quinine; Respiratory Insufficiency; Splenectomy; Transfusion Reaction | 2011 |
1 other study(ies) available for clindamycin and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
[Necrotizing subcutaneous infection by Streptococcus agalactiae].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clindamycin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Elbow Injuries; Fasciitis, Necrotizing; Humans; Immunocompromised Host; Leg; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Soft Tissue Infections; Streptococcus agalactiae; Wound Infection | 2006 |